Published in EMBO J on April 01, 2003
Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res (2007) 1.71
Determinants of the inherent strength of human 5' splice sites. RNA (2005) 1.69
Intrinsic differences between authentic and cryptic 5' splice sites. Nucleic Acids Res (2003) 1.66
hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes. Nucleic Acids Res (2004) 1.45
Pick one, but be quick: 5' splice sites and the problems of too many choices. Genes Dev (2013) 1.39
Genomic splice-site analysis reveals frequent alternative splicing close to the dominant splice site. RNA (2006) 1.22
Extended base pair complementarity between U1 snRNA and the 5' splice site does not inhibit splicing in higher eukaryotes, but rather increases 5' splice site recognition. Nucleic Acids Res (2005) 1.17
Recognition of atypical 5' splice sites by shifted base-pairing to U1 snRNA. Nat Struct Mol Biol (2009) 1.16
Phylogenetically widespread alternative splicing at unusual GYNGYN donors. Genome Biol (2006) 1.09
Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns. Genome Biol (2007) 1.01
Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides. Genes Dev (2012) 0.98
Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor. Mol Endocrinol (2007) 0.91
A comprehensive survey of non-canonical splice sites in the human transcriptome. Nucleic Acids Res (2014) 0.90
Comparative analysis of sequence features involved in the recognition of tandem splice sites. BMC Genomics (2008) 0.88
FRS2α is essential for the fibroblast growth factor to regulate the mTOR pathway and autophagy in mouse embryonic fibroblasts. Int J Biol Sci (2011) 0.82
Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations. Orphanet J Rare Dis (2014) 0.80
Noncanonical registers and base pairs in human 5' splice-site selection. Nucleic Acids Res (2016) 0.77
Diverse captive non-human primates with phytanic acid-deficient diets rich in plant products have substantial phytanic acid levels in their red blood cells. Lipids Health Dis (2013) 0.76
Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension. Sci Rep (2017) 0.75
A mechanism for a single nucleotide intron shift. Nucleic Acids Res (2017) 0.75
RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res (2001) 45.29
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell (1995) 21.15
Mechanical devices of the spliceosome: motors, clocks, springs, and things. Cell (1998) 10.95
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci (2000) 10.77
Exon recognition in vertebrate splicing. J Biol Chem (1995) 10.08
A compensatory base change in U1 snRNA suppresses a 5' splice site mutation. Cell (1986) 9.65
Sorting out the complexity of SR protein functions. RNA (2000) 9.25
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell (1990) 8.11
Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci (2000) 7.54
Fibroblast growth factors. Genome Biol (2001) 7.32
Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu Rev Genet (1998) 7.15
Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell (2000) 5.16
Regulation of alternative splicing by RNA editing. Nature (1999) 5.00
Split genes and RNA splicing. Cell (1994) 4.94
Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res (1993) 4.67
Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol (2001) 4.64
U5 snRNA interacts with exon sequences at 5' and 3' splice sites. Cell (1992) 4.42
Sequence requirements for splicing of higher eukaryotic nuclear pre-mRNA. Cell (1986) 4.40
Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res (2000) 4.29
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med (1999) 4.22
The U5 and U6 small nuclear RNAs as active site components of the spliceosome. Science (1993) 3.83
Initial splice-site recognition and pairing during pre-mRNA splicing. Curr Opin Genet Dev (1996) 3.68
Mutations in U6 snRNA that alter splice site specificity: implications for the active site. Science (1993) 3.62
Involvement of U6 snRNA in 5' splice site selection. Science (1993) 3.51
A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res (1991) 3.44
U6 small nuclear RNA is transcribed by RNA polymerase III. Proc Natl Acad Sci U S A (1986) 3.14
A putative ATP binding protein influences the fidelity of branchpoint recognition in yeast splicing. Cell (1990) 3.06
Mutations in yeast U5 snRNA alter the specificity of 5' splice-site cleavage. Cell (1991) 2.91
Classification of introns: U2-type or U12-type. Cell (1997) 2.91
The human gene mutation database. Trends Genet (1997) 2.72
A mechanism to enhance mRNA splicing fidelity: the RNA-dependent ATPase Prp16 governs usage of a discard pathway for aberrant lariat intermediates. Cell (1993) 2.70
5' cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 5' splice region, not by the conserved 5' GU. Cell (1987) 2.69
Mechanisms of fidelity in pre-mRNA splicing. Curr Opin Cell Biol (2000) 2.66
SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev (1994) 2.55
Pre-mRNA splicing: the discovery of a new spliceosome doubles the challenge. Trends Biochem Sci (1997) 2.19
Two domains of yeast U6 small nuclear RNA required for both steps of nuclear precursor messenger RNA splicing. Science (1990) 2.13
The ins and outs of fibroblast growth factors. Cell (1994) 1.95
Fibroblast growth factor receptors from liver vary in three structural domains. Science (1991) 1.82
The HIV-1 5' LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site. EMBO J (1997) 1.72
Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions. Nucleic Acids Res (2001) 1.65
Exon mutations uncouple 5' splice site selection from U1 snRNA pairing. Cell (1990) 1.53
Evidence for splice site pairing via intron definition in Schizosaccharomyces pombe. Mol Cell Biol (2000) 1.34
Suppression of mammalian 5' splice-site defects by U1 small nuclear RNAs from a distance. Proc Natl Acad Sci U S A (1994) 1.23
A U6 snRNA:pre-mRNA interaction can be rate-limiting for U1-independent splicing. Genes Dev (1995) 1.23
U1 snRNA promotes the selection of nearby 5' splice sites by U6 snRNA in mammalian cells. Genes Dev (1996) 1.17
Genetic interaction between U6 snRNA and the first intron nucleotide in Saccharomyces cerevisiae. RNA (1998) 1.11
Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene (2000) 1.10
Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain. J Biol Chem (2001) 1.10
Transcription and polyadenylation in a short human intergenic region. Nucleic Acids Res (1997) 1.06
Influences of separation and adjacent sequences on the use of alternative 5' splice sites. J Mol Biol (1991) 1.04
Comparative studies of Drosophila Antennapedia genes. Genetics (1992) 1.01
Conserved use of a non-canonical 5' splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3. Hum Mol Genet (1998) 0.92
Activation of a cryptic 5' splice site by U1 snRNA. RNA (2001) 0.90
Cloning of a fibroblast growth factor receptor 1 splice variant from Xenopus embryos that lacks a protein kinase C site important for the regulation of receptor activity. J Biol Chem (1995) 0.85
The VT+ and VT- isoforms of the fibroblast growth factor receptor type 1 are differentially expressed in the presumptive mesoderm of Xenopus embryos and differ in their ability to mediate mesoderm formation. J Biol Chem (2000) 0.81
The structure and expression of the FGF receptor-1 mRNA isoforms in rat tissues. Biochim Biophys Acta (1993) 0.80
The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res (2013) 5.66
Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science (2003) 3.39
Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet (2003) 3.23
Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR. Nat Genet (2004) 2.72
Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat (2005) 2.58
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci U S A (2004) 2.01
Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet (2002) 1.88
Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet (2013) 1.87
Craniosynostosis. Eur J Hum Genet (2011) 1.84
Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82
Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet (2012) 1.78
Duplications of noncoding elements 5' of SOX9 are associated with brachydactyly-anonychia. Nat Genet (2009) 1.75
Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet (2006) 1.74
Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet (2009) 1.72
RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet (2007) 1.72
Reoperation for intracranial hypertension in TWIST1-confirmed Saethre-Chotzen syndrome: a 15-year review. Plast Reconstr Surg (2009) 1.68
An in-depth analysis of original antigenic sin in dengue virus infection. J Virol (2010) 1.63
Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood (2006) 1.61
Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox gene. Am J Hum Genet (2009) 1.57
Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 1.52
A variant in the sonic hedgehog regulatory sequence (ZRS) is associated with triphalangeal thumb and deregulates expression in the developing limb. Hum Mol Genet (2008) 1.37
HIV-1 down-regulates the expression of CD1d via Nef. Eur J Immunol (2006) 1.36
Gain-of-function amino acid substitutions drive positive selection of FGFR2 mutations in human spermatogonia. Proc Natl Acad Sci U S A (2005) 1.35
Following a TRAIL: update on a ligand and its five receptors. Cell Res (2004) 1.33
Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E. Am J Hum Genet (2003) 1.29
Expression of TRAIL and TRAIL receptors in normal and malignant tissues. Cell Res (2005) 1.25
The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males. Am J Hum Genet (2006) 1.22
Frontometaphyseal dysplasia: mutations in FLNA and phenotypic diversity. Am J Med Genet A (2006) 1.20
Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet (2011) 1.17
Enlarged parietal foramina caused by mutations in the homeobox genes ALX4 and MSX2: from genotype to phenotype. Eur J Hum Genet (2006) 1.14
Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome. Dev Dyn (2009) 1.11
Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity. J Immunol (2012) 1.07
Hearing loss in a mouse model of Muenke syndrome. Hum Mol Genet (2008) 1.07
Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3. Am J Med Genet A (2007) 1.04
High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. J Virol (2013) 1.03
T cell responses to whole SARS coronavirus in humans. J Immunol (2008) 1.03
Etiological heterogeneity and clinical characteristics of metopic synostosis: Evidence from a tertiary craniofacial unit. Am J Med Genet A (2010) 1.03
Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes. Hum Mol Genet (2013) 1.02
Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome. Arthritis Res Ther (2007) 1.02
Alx4 and Msx2 play phenotypically similar and additive roles in skull vault differentiation. J Anat (2004) 1.02
Atypical Crouzon syndrome with a novel Cys62Arg mutation in FGFR2 presenting with sagittal synostosis. Cleft Palate Craniofac J (2011) 1.00
Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction. J Immunol (2009) 1.00
"Selfish spermatogonial selection": a novel mechanism for the association between advanced paternal age and neurodevelopmental disorders. Am J Psychiatry (2013) 1.00
Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline. Proc Natl Acad Sci U S A (2013) 1.00
Polydactyly in the mouse mutant Doublefoot involves altered Gli3 processing and is caused by a large deletion in cis to Indian hedgehog. Mech Dev (2008) 0.99
An acceptor splice site mutation in HOXD13 results in variable hand, but consistent foot malformations. Am J Med Genet A (2003) 0.98
Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily. Hum Mutat (2009) 0.98
Missing heritability: paternal age effect mutations and selfish spermatogonia. Nat Rev Genet (2010) 0.97
Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development (2003) 0.96
Expanding the phenotype of craniofrontonasal syndrome: two unrelated boys with EFNB1 mutations and congenital diaphragmatic hernia. Eur J Hum Genet (2006) 0.96
Metopic and sagittal synostosis in Greig cephalopolysyndactyly syndrome: five cases with intragenic mutations or complete deletions of GLI3. Eur J Hum Genet (2011) 0.96
FGFR3 P250R mutation increases the risk of reoperation in apparent 'nonsyndromic' coronal craniosynostosis. J Craniofac Surg (2005) 0.95
Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis. Hum Genet (2004) 0.95
Postzygotic mutation and germline mosaicism in the otopalatodigital syndrome spectrum disorders. Eur J Hum Genet (2006) 0.94
Enhanced immune recognition of cryptic glycan markers in human tumors. Cancer Res (2009) 0.93
Parietal foramina with cleidocranial dysplasia is caused by mutation in MSX2. Eur J Hum Genet (2003) 0.93
A new locus for split hand/foot malformation with long bone deficiency (SHFLD) at 2q14.2 identified from a chromosome translocation. Hum Genet (2007) 0.91
Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes. Am J Med Genet A (2010) 0.91
Functional analysis of natural mutations in two TWIST protein motifs. Hum Mutat (2005) 0.90
Mutations in multidomain protein MEGF8 identify a Carpenter syndrome subtype associated with defective lateralization. Am J Hum Genet (2012) 0.89
Frank-ter Haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure. BMC Med Genet (2012) 0.89
Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling. J Biol Chem (2011) 0.89
Fas ligand breaks tolerance to self-antigens and induces tumor immunity mediated by antibodies. Cancer Cell (2002) 0.88
MHC/peptide tetramer-based studies of T cell function. J Immunol Methods (2002) 0.88
Selfish spermatogonial selection: evidence from an immunohistochemical screen in testes of elderly men. PLoS One (2012) 0.85
A further mutation of the FGFR2 tyrosine kinase domain in mild Crouzon syndrome. Eur J Hum Genet (2005) 0.85
Fibroblast growth factor receptor 2, gain-of-function mutations, and tumourigenesis: investigating a potential link. J Pathol (2005) 0.85
Implications of a vertex bulge following modified strip craniectomy for sagittal synostosis. Plast Reconstr Surg (2008) 0.85
Carpenter syndrome: extended RAB23 mutation spectrum and analysis of nonsense-mediated mRNA decay. Hum Mutat (2011) 0.85
Generation and characterisation of CD1d tetramer produced by a lentiviral expression system. J Immunol Methods (2007) 0.84
Characterisation of monoclonal antibodies to the TNF and TNF receptor families. Cell Immunol (2005) 0.83
The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. J Virol (2009) 0.83
A novel role of CD1c in regulating CD1d-mediated NKT cell recognition by competitive binding to Ig-like transcript 4. Int Immunol (2012) 0.82
A deletion of FGFR2 creating a chimeric IIIb/IIIc exon in a child with Apert syndrome. BMC Med Genet (2011) 0.82
Mutational screening of FGFR1, CER1, and CDON in a large cohort of trigonocephalic patients. Cleft Palate Craniofac J (2006) 0.81
Scalp fibroblasts have a shared expression profile in monogenic craniosynostosis. J Med Genet (2009) 0.81
Cancer drugs to treat birth defects. Nat Genet (2007) 0.81
CTLs target Th cells that acquire bystander MHC class I-peptide complex from APCs. J Immunol (2007) 0.81
Recessive omodysplasia: five new cases and review of the literature. Pediatr Radiol (2003) 0.80
Duplication of the EFNB1 gene in familial hypertelorism: imbalance in ephrin-B1 expression and abnormal phenotypes in humans and mice. Hum Mutat (2011) 0.79
Pure de novo partial trisomy 6p in a girl with craniosynostosis. Am J Med Genet A (2013) 0.79
Monozygotic twins discordant for frontonasal malformation. Am J Med Genet A (2004) 0.79
Raised intracranial pressure is frequent in untreated nonsyndromic unicoronal synostosis and does not correlate with severity of phenotypic features. Plast Reconstr Surg (2012) 0.79
The fibroblast growth factor receptor 2 p.Ala172Phe mutation in Pfeiffer syndrome--history repeating itself. Am J Med Genet A (2013) 0.79
Homozygous SALL1 mutation causes a novel multiple congenital anomaly-mental retardation syndrome. J Pediatr (2012) 0.78
Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand. Int Immunol (2008) 0.77
Clinical hypochondroplasia in a family caused by a heterozygous double mutation in FGFR3 encoding GLY380LYS. Am J Med Genet A (2007) 0.77
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2015) 0.76
Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature (2016) 0.76
A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues. Hum Immunol (2004) 0.76
'Sifting the significance from the data' - the impact of high-throughput genomic technologies on human genetics and health care. Hum Genomics (2012) 0.75
Genetic aspects of birth defects: new understandings of old problems. Arch Dis Child Fetal Neonatal Ed (2007) 0.75
Median facial cleft dysmorphism in three siblings: case report and review of the literature. Letter. Cleft Palate Craniofac J (2010) 0.75
Abnormal spliceform expression associated with splice acceptor mutations in exon IIIc of FGFR2. Am J Med Genet (2002) 0.75
Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol (2015) 0.75